Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Share-based Compensation (2017 - 2025)

Catheter Precision (VTAK) has disclosed Share-based Compensation for 9 consecutive years, with $79000.0 as the latest value for Q4 2025.

  • Quarterly Share-based Compensation rose 338.89% to $79000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $540000.0 through Dec 2025, up 900.0% year-over-year, with the annual reading at $338000.0 for FY2025, 525.93% up from the prior year.
  • Share-based Compensation for Q4 2025 was $79000.0 at Catheter Precision, up from $70000.0 in the prior quarter.
  • The five-year high for Share-based Compensation was $1.4 million in Q1 2023, with the low at -$5000.0 in Q4 2023.
  • Average Share-based Compensation over 5 years is $225000.0, with a median of $80500.0 recorded in 2022.
  • The sharpest move saw Share-based Compensation tumbled 106.1% in 2023, then soared 2207.69% in 2025.
  • Over 5 years, Share-based Compensation stood at $87000.0 in 2021, then fell by 5.75% to $82000.0 in 2022, then crashed by 106.1% to -$5000.0 in 2023, then soared by 460.0% to $18000.0 in 2024, then surged by 338.89% to $79000.0 in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $79000.0, $70000.0, and $300000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.